Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Diffusil H Forte Spray for Pediculosis
2007-002463-27Phase 3Completed
- Sponsor
- Laboratorios Lybar
- Start
- Aug 2007
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of carbaryl in pediculosis, sponsored by Laboratorios Lybar. Primary endpoint: Safety of Diffusil H Forte spray. Started Aug 2007; status: completed.
02
Drugs
carbaryl
03
Conditions
pediculosis
Beyond the preview
Go deeper on 2007-002463-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002463-27.